SelectQuote (NYSE:SLQT – Get Free Report) is one of 311 publicly-traded companies in the “Insurance” industry, but how does it weigh in compared to its competitors? We will compare SelectQuote to similar companies based on the strength of its dividends, analyst recommendations, valuation, earnings, profitability, institutional ownership and risk.
Insider and Institutional Ownership
34.6% of SelectQuote shares are owned by institutional investors. Comparatively, 55.9% of shares of all “Insurance” companies are owned by institutional investors. 11.6% of SelectQuote shares are owned by company insiders. Comparatively, 13.4% of shares of all “Insurance” companies are owned by company insiders. Strong institutional ownership is an indication that large money managers, endowments and hedge funds believe a stock will outperform the market over the long term.
Analyst Recommendations
This is a summary of recent ratings for SelectQuote and its competitors, as reported by MarketBeat.
| Sell Ratings | Hold Ratings | Buy Ratings | Strong Buy Ratings | Rating Score | |
| SelectQuote | 1 | 2 | 0 | 1 | 2.25 |
| SelectQuote Competitors | 3351 | 15721 | 16571 | 747 | 2.40 |
SelectQuote currently has a consensus target price of $3.00, indicating a potential upside of 586.50%. As a group, “Insurance” companies have a potential upside of 4.15%. Given SelectQuote’s higher probable upside, research analysts plainly believe SelectQuote is more favorable than its competitors.
Profitability
This table compares SelectQuote and its competitors’ net margins, return on equity and return on assets.
| Net Margins | Return on Equity | Return on Assets | |
| SelectQuote | 4.61% | 22.48% | 6.06% |
| SelectQuote Competitors | 9.46% | -10.06% | 4.09% |
Valuation & Earnings
This table compares SelectQuote and its competitors revenue, earnings per share (EPS) and valuation.
| Gross Revenue | Net Income | Price/Earnings Ratio | |
| SelectQuote | $1.57 billion | $62.19 million | -14.57 |
| SelectQuote Competitors | $15.17 billion | $1.70 billion | 34.05 |
SelectQuote’s competitors have higher revenue and earnings than SelectQuote. SelectQuote is trading at a lower price-to-earnings ratio than its competitors, indicating that it is currently more affordable than other companies in its industry.
Risk & Volatility
SelectQuote has a beta of 2.01, meaning that its stock price is 101% more volatile than the S&P 500. Comparatively, SelectQuote’s competitors have a beta of -1.59, meaning that their average stock price is 259% less volatile than the S&P 500.
Summary
SelectQuote competitors beat SelectQuote on 8 of the 13 factors compared.
SelectQuote Company Profile
SelectQuote, Inc. operates a direct-to-consumer insurance distribution platform that helps consumers compare coverage from multiple insurance providers. Its licensed agents assist customers with evaluating options and selecting policies. The company offers Medicare-related products, including Medicare Advantage, Medicare Supplement and prescription drug plans, as well as life, auto and home insurance. Its services also include SelectRx, which provides pharmacy and medication-management services.
Receive News & Ratings for SelectQuote Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for SelectQuote and related companies with MarketBeat.com's FREE daily email newsletter.
